Predictors of hemorrhage volume and disability after perimesencephalic subarachnoid hemorrhage

Neurology

Volumn 78, Issue 11, 2012, Pages 811-815

  Naidech, A M ^a   Rosenberg, N F ^a   Maas, M B ^a   Bendok, B R ^a   Batjer, H H ^a   Nemeth, A J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DISABILITY; DISEASE SEVERITY; DRUG USE; FEMALE; HUMAN; HYDROCEPHALUS; MALE; MESENCEPHALON; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE DIAGNOSIS; SUBARACHNOID HEMORRHAGE; THROMBOCYTE FUNCTION; AGED; BLOOD; BLOOD CLOTTING PARAMETERS; BRAIN ANGIOGRAPHY; BRAIN CIRCULATION; BRAIN VEIN; BRAIN VENTRICLE PERITONEUM SHUNT; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; INTRACRANIAL ANEURYSM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; VASCULARIZATION;

ADULT; AGED; ASPIRIN; CEREBRAL ANGIOGRAPHY; CEREBRAL VEINS; CEREBROVASCULAR CIRCULATION; COHORT STUDIES; DISABILITY EVALUATION; FEMALE; HUMANS; HYDROCEPHALUS; INTRACRANIAL ANEURYSM; MALE; MESENCEPHALON; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; SUBARACHNOID HEMORRHAGE; TOMOGRAPHY, X-RAY COMPUTED; VENTRICULOPERITONEAL SHUNT;

EID: 84859928731     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318249f6dc     Document Type: Article

References (23)

1. Mayer SA, Bernardini GL, Solomon RA. Subarachnoid hemorrhage. In: Rowland LP, Pedley TA, eds. Merritt's Neurology, 12th ed. Philadelphia: Lippincott Williams & Wilkins; 2010.
2. Rinkel GJE, Wijdicks EFM, van Gijn J, et al. Outcome in patients with subarachnoid haemorrhage and negative angiography according to pattern of haemorrhage on computed tomography. Lancet 1991;338:964-968.
3. Rinkel GJE, Wijdicks EFM, Vermeulen M, Hasan D, Brouwers PJAM, van Gijn J. The clinical course of perimesencephalic nonaneurysmal subarachnoid hemorrhage. Ann Neurol 1991;29:463-468.
4. Brilstra EH, Hop JW, Rinkel GJE. Quality of life after perimesencephalic haemorrhage. J Neurol Neurosurg Psychiatry 1997;63:382-384. (Pubitemid 27412384)
5. Greebe P, Rinkel GJE. Life expectancy after perimesencephalic subarachnoid hemorrhage. Stroke 2007;38:1222-1224. (Pubitemid 351664284)
6. Hashimoto H, Iida J-I, Hironaka Y, Okada M, Sakaki T. Use of spiral computerized tomography angiography in patients with subarachnoid hemorrhage in whom subtraction angiography did not reveal cerebral aneurysms. J Neurosurg 2000;92:278-283. (Pubitemid 30071047)
7. Topcuoglu MA, Ogilvy CS, Carter BS, Buonanno FS, Koroshetz WJ, Singhal AB. Subarachnoid hemorrhage without evident cause on initial angiography studies: Diagnostic yield of subsequent angiography and other neuroimaging tests. J Neurosurg 2003;98:1235-1240. (Pubitemid 36617927)
8. Brinjikji W, Kallmes DF, White JB, Lanzino G, Morris JM, Cloft HJ. Inter- and intraobserver agreement in CT characterization of nonaneurysmal perimesencephalic subarachnoid hemorrhage. AJNR Am J Neuroradiol 2010;31: 1103-1105.
9. Hui F, Tumialán L, Tanaka T, Cawley C, Zhang Y. Clinical differences between angiographically negative, diffuse subarachnoid hemorrhage and perimesencephalic subarachnoid hemorrhage. Neurocritical Care 2009;11: 64-70.
10. Beseoglu K, Pannes S, Steiger H, Hänggi D. Long-term outcome and quality of life after nonaneurysmal subarachnoid hemorrhage. Acta Neurochir 2010;152:409-416.
11. van der Schaaf IC, Velthuis BK, Gouw A, Rinkel GJE. Venous drainage in perimesencephalic hemorrhage. Stroke 2004;35:1614-1618. (Pubitemid 38823635)
12. Yamakawa H, Ohe N, Yano H, Yoshimura S, Iwama T. Venous drainage patterns in perimesencephalic nonaneurysmal subarachnoid hemorrhage. Clin Neurol Neurosurg 2008;110:587-591.
13. Naidech AM, Jovanovic B, Liebling S, et al. Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage. Stroke 2009;40:2398-2401.
14. Thompson BB, Bejot Y, Caso V, et al. Prior antiplatelet therapy and outcome following intracerebral hemorrhage: A systematic review. Neurology 2010;75:1333-1342.
15. Watanabe A, Hirano K, Kamada M, et al. Perimesencephalic nonaneurysmal subarachnoid haemorrhage and variations in the veins. Neuroradiol 2002;44:319-325. (Pubitemid 36097177)
16. VerifyNow aspirin package insert. 14314-WEB.B ed. San Diego, CA: Accumetrics, Inc.
17. Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008;358:2127-2137. (Pubitemid 351679599)
18. Claassen J, Bernardini GL, Kreiter K, et al. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: The Fisher scale revisited. Stroke 2001;32:2012-2020. (Pubitemid 32868089)
19. Banks J, Marotta C. Outcomes validity and reliability of the modified Rankin scale: Implications for stroke clinical trials: A literature review and synthesis. Stroke 2007;38: 1091-1096. (Pubitemid 46568483)
20. Wilson JTL, Hareendran A, Grant M, et al. Improving the assessment of outcomes in stroke: Use of a structured interview to assign grade on the modified Rankin Scale. Stroke 2002;33:2243-2246. (Pubitemid 35014637)
21. Goldenberg NA, Jacobson L, Manco-Johnson MJ. Duration of platelet dysfunction after a 7-day course of ibuprofen. Ann Intern Med 2005;142:506-509.
22. Naidech AM, Bassin SL, Bernstein RA, et al. Reduced platelet activity is more common than reported antiplatelet medication use in patients with intracerebral hemorrhage. Neurocrit Care 2009;11:307-310.
23. Lordkipanidze M, Pharand C, Schampaert E, Turgeon J, Palisaitis D, Diodati J. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J 2007;28:1702-1708. (Pubitemid 47227104)